Xcell Biosciences

15 articles about Xcell Biosciences

• Xcell Biosciences Strengthens Cell and Gene Therapy Collaboration With Labcorp

  4/1/2024

  Xcell Biosciences Inc. today announced it has added new elements to its research collaboration agreement with Labcorp, a global leader of innovative and comprehensive laboratory services.

• Xcell Biosciences Announces New Scientific and Business Advisory Board

  3/27/2024

  Xcell Biosciences Inc., an instrumentation company focused on cell and gene therapy applications, announced the formation of a new scientific and business advisory board composed of some of the leading minds in the industry.

• Xcell Biosciences Announces Collaboration with ElevateBio to Advance Technology Development for Cell and Gene Therapies

  1/11/2024

  Xcell Biosciences, Inc. today announced a collaboration with ElevateBio, LLC (ElevateBio), through which the companies aim to explore novel approaches to improving therapeutic potency of cell and gene therapies.

• Xcell Biosciences and Labcorp Achieve Key Data Milestones in Cell and Gene Therapy Collaboration

  8/24/2023

  Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, today announced it has achieved key milestones in its R&D collaboration with Labcorp, a global leader of innovative and comprehensive laboratory services, aimed at driving innovation in the development and validation of cell and gene therapies.

• Xcell Biosciences and aCGT Vector Collaborate to Accelerate Development of Cell and Gene Therapies

  10/13/2022

  Xcell Biosciences Inc. today announced a collaboration to improve manufacturing and analytic procedures used to develop personalized cell and gene therapies for cancer patients.

• Xcell Biosciences Appoints Shannon Eaker, Ph.D. as Chief Technology Officer

  5/3/2022

  Xcell Biosciences Inc. today announced the appointment of Shannon Eaker, Ph.D., as its Chief Technology Officer.

• Labcorp Enhances Cell and Gene Therapy Development Support Through Collaboration With Xcell Biosciences

  4/19/2022

  Labcorp (NYSE: LH), a leading global life sciences company, is collaborating with Xcell Biosciences, Inc. (Xcellbio), a leading developer of cell and gene therapy technologies, to advance critical work that helps clients effectively bring innovative cell and gene therapies to market.

• Xcellbio Announces $27.5 Million Series B Financing

  1/19/2022

  Xcell Biosciences, Inc. today announced $27.5 million in Series B financing led by Casdin Capital.

• Xcell Biosciences Announces $12 Million Series A Funding Round

  2/16/2017

• Xcell Biosciences Announces Two New International Distributors And Multiple International System Sales For The Avatar System

  10/4/2016

• Xcell Biosciences Initiates New Collaborations With UCSF Researchers Studying Effectiveness Of Immunotherapy In Urologic Cancers

  9/22/2016

• Xcell Biosciences Initiates New Collaborations With UCSF Researchers Studying Effectiveness Of Immunotherapy In Urologic Cancers

  9/22/2016

• Xcell Biosciences Selected As A 2016 Red Herring Top 100 North America Winner

  6/15/2016

• Xcell Biosciences To Present Data From Its Avatar System At ISSCR Annual Meeting

  6/13/2016

• Xcell Biosciences To Introduce Next Generation System For Cell-based Assays At The 2016 Molecular Medicine Tri-Conference

  3/2/2016